Back
Oramed Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
39
ORMP
Oramed Pharmaceuticals
Last Price:
2.33
Seasonality Move:
22.85%
Sell
40
NBY
NovaBay Pharmaceuticals
Last Price:
0.73
Seasonality Move:
-7.72%
Sell
39
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy, Sell or Hold?
- The current Oramed Pharmaceuticals [ORMP] share price is $2.33. The Score for ORMP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ORMP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ORMP Stock Price Chart
What is Oramed Pharmaceuticals's stock price today?
-
The Oramed Pharmaceuticals share price today is $2.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.71
The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
ORMP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 46.77 | Sell |
| Chaikin Money Flow: | -8376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.33 - 2.39) | Sell |
| Bollinger Bands (100): | (2.32 - 2.52) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 53.84 | Buy |
| Chaikin Money Flow: | -257778 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.59 - 0.73) | Buy |
| Bollinger Bands (100): | (0.28 - 1.62) | Sell |
ORMP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.34 | Sell |
| 20-day SMA: | 2.35 | Sell |
| 50-day SMA: | 2.38 | Sell |
| 200-day SMA: | 2.52 | Sell |
| 8-day EMA: | 2.34 | Sell |
| 20-day EMA: | 2.35 | Sell |
| 50-day EMA: | 2.37 | Sell |
| 200-day EMA: | 2.51 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.73 | Sell |
| 20-day SMA: | 0.67 | Buy |
| 50-day SMA: | 0.63 | Buy |
| 200-day SMA: | 2.49 | Sell |
| 8-day EMA: | 0.72 | Sell |
| 20-day EMA: | 0.69 | Buy |
| 50-day EMA: | 0.74 | Sell |
| 200-day EMA: | 5.92 | Sell |
Oramed Pharmaceuticals Earnings Growth & ORMP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.43 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Oramed Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||